Ulysses Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,000
Closed -$978K 44
2026
Q1
$978K Hold
4,000
0.12% 32
2025
Q4
$828K Buy
+4,000
New +$791K 0.15% 41
2016
Q4
Sell
-10,000
Closed -$1.18M 49
2016
Q3
$1.18M Hold
10,000
0.14% 40
2016
Q2
$1.21M Sell
10,000
-2,500
-20% -$284K 0.14% 36
2016
Q1
$1.35M Hold
12,500
0.15% 45
2015
Q4
$1.28M Hold
12,500
0.16% 45
2015
Q3
$1.17M Buy
+12,500
New +$1.21M 0.12% 44
2013
Q3
Sell
-175,000
Closed -$15M 53
2013
Q2
$15M Buy
+175,000
New +$14.9M 2.4% 7

Other funds holding JNJ

Ulysses Management's JNJ Position: Q2 2026 in Review

Ulysses Management sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 4,000 shares — an estimated $978K sold.

Ulysses Management first reported a position in JNJ in Q2 2013 and held it in 8 quarters. The position peaked at $15M in Q2 2013. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ulysses Management reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Ulysses Management sold 4,000 Johnson & Johnson shares in Q2 2026, an estimated $978K.
  • Ulysses Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 8 quarters.
  • Ulysses Management's Johnson & Johnson position peaked at $15M in Q2 2013.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ulysses Management's 13F filing for Q2 2026, filed 14 Aug 2026.